![Philippe Lluel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Philippe Lluel
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
IXALTIS SAS
![]() IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Profilomic SA
![]() Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France.
3
| Private Company | Medical/Nursing Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Philippe Lluel tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
REGENXBIO INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
STALLERGENES | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
IRDI Capital Investissement SAS
![]() IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Sofimac Innovation SAS
![]() Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Director/Board Member Private Equity Investor | |
Sud Ouest Capital Risque Innovation SAS
![]() Sud Ouest Capital Risque Innovation SAS Investment ManagersFinance Sud Ouest Capital Risque Innovation SAS invests in innovative companies established in the Aquitaine and Midi-Pyrénées regions. The fund invests in the range of €150,000 - €1 million per transaction and also makes co-investments. | Investment Managers | Chairman | |
TELECOM DESIGN | Specialty Telecommunications | Director/Board Member | |
University College London | College/University | Corporate Officer/Principal | |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
University of Orsay | College/University | Graduate Degree | |
IXO Private Equity SAS
![]() IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investment Managers | Private Equity Investor Private Equity Investor | |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Xyence Capital SGR
![]() Xyence Capital SGR Investment ManagersFinance Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy. | Investment Managers | Private Equity Investor | |
ImmunID SAS
![]() ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member | |
Leo Pharma, Inc.
![]() Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member | |
Centre National de la Recherche Scientifique
![]() Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Chief Tech/Sci/R&D Officer | |
European Society of Gene & Cell Therapy | President | ||
Kadmon Pharmaceuticals LLC
![]() Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CASiGEN Pharma Ltd. | Chairman | ||
Ventac Partners LLC | Founder | ||
Genethon
![]() Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Antabio SAS
![]() Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Pharmaceuticals: Major | Director/Board Member | |
Wise Srl
![]() Wise Srl BiotechnologyHealth Technology WISE Srl operates as a biomedical company which engages in the development of neuromodulation and neuromonitoring devices. It offers scbi technology, stretchability, micropatterning, biocompatibility and effective stimulation. The company was founded by Cristian Ghisleri, Luca Ravagnan, Mario Zanone Poma and Paolo Milani in 2011 and is headquartered in Cologno Monzese, Italy. | Biotechnology | Director/Board Member | |
IDOGEN AB (PUBL) | Biotechnology | Director/Board Member | |
LYSOGENE | Miscellaneous Commercial Services | Founder | |
Amolyt Pharma SAS
![]() Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ffly4u SAS
![]() ffly4u SAS Specialty TelecommunicationsCommunications Ffly4u SASU provides a low frequency localization services for mobile assets. It also offers services like movement, temperature, noise or opening detection in order to guarantee the integrity of sensitive assets. The company was founded by Pages Olivier in 2015 and is headquartered in Toulouse, France. | Specialty Telecommunications | Director/Board Member | |
FineHeart SA
![]() FineHeart SA Pharmaceuticals: MajorHealth Technology FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tritone Mare di Galeotti Marco & C. SNC
![]() Tritone Mare di Galeotti Marco & C. SNC RestaurantsConsumer Services Tritone Mare di Galeotti Marco & C. SNC operates restaurants. The private company is based in Sarzana, Italy. | Restaurants | Corporate Officer/Principal | |
Rigenerand Srl
![]() Rigenerand Srl Medical SpecialtiesHealth Technology Rigenerand Srl operates as a biotechnology company. It develops and produces biomedical devices that support the culture of stem cells for pre-clinical and clinical applications. The company was founded by Massimo Dominici and Pierfranco Conte in 2009 and is headquartered in Medolla, Italy. | Medical Specialties | Chairman | |
Horama SA
![]() Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
CUBE Labs Srl
![]() CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
Backbone SAS
![]() Backbone SAS Medical SpecialtiesHealth Technology Backbone SAS is a venture capital and private equity firm. It specializes in investments in late venture companies, startups, buyouts, growth financing, leveraged buyouts, and buyins. The company was founded by Nazanine Sahami on March 25, 2015 and is headquartered in Le Bouscat, France. | Medical Specialties | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
MicroPEP Technologies SAS
![]() MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
Gada SpA
![]() Gada SpA Medical DistributorsDistribution Services Gada SpA is a holding company, which engages in the provision of integrated healthcare solutions. It offers cardiovascular, blood and infusion management, and intensive care services. The company was founded in 1978 and is headquartered in Rome, Italy. | Medical Distributors | Director/Board Member | |
TreeFrog Therapeutics SAS
![]() TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
Orbit Genomics, Inc.
![]() Orbit Genomics, Inc. Packaged SoftwareTechnology Services Orbit Genomics, Inc. operates as a technology platform for early disease detection, treatment, and prevention of diseases. The company is based in Boulder, CO. The company was founded by Elizabeth Willis, Harold Garner. Elizabeth Willis has been the CEO since incorporation. | Packaged Software | Chairman | |
Swallis Medical SAS
![]() Swallis Medical SAS Miscellaneous Commercial ServicesCommercial Services Swallis Medical SAS engages in the provision of diagnostic and monitoring solutions for problem of swallowing disorders. The company was founded by Linda Nicolini in 2019 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
Kuste Biopharma SAS
![]() Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
COEGIN PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Firalis SA
![]() Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Corlieve Therapeutics SAS
![]() Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Francia | 27 |
Stati Uniti | 10 |
Italia | 7 |
Svezia | 4 |
Svizzera | 2 |
Settori
Health Technology | 24 |
Finance | 8 |
Commercial Services | 6 |
Consumer Services | 5 |
Communications | 3 |
Posizioni
Director/Board Member | 93 |
Chairman | 24 |
Corporate Officer/Principal | 24 |
Chief Executive Officer | 14 |
Founder | 9 |
Contatti più connessi
Insiders | |
---|---|
François Miceli | 43 |
Jean-Michel Petit | 24 |
Christian Chavy | 18 |
Mikael Oerum | 17 |
Lena Elisabeth Svanberg | 16 |
Olivier Danos | 15 |
Paolo Daniele Siviero | 12 |
Roberto Gradnik | 11 |
Hasnaa Hafid | 5 |
Mario Caria | 4 |
Hüseyin Firat | 4 |
Fuat Firat | 2 |
Stefano Palea | 1 |
Pascal Rischmann | 1 |
Xavier Gamé | 1 |
- Borsa valori
- Insiders
- Philippe Lluel
- Connessioni Società